{"id":63176,"date":"2026-04-17T16:32:08","date_gmt":"2026-04-17T14:32:08","guid":{"rendered":"https:\/\/carlosoconnor.es\/?p=63176"},"modified":"2026-04-17T16:32:11","modified_gmt":"2026-04-17T14:32:11","slug":"prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento","status":"publish","type":"post","link":"https:\/\/carlosoconnor.es\/en\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/","title":{"rendered":"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento"},"content":{"rendered":"<p>Las variaciones en la anatom\u00eda de las v\u00edas respiratorias superiores y el tono far\u00edngeo son factores que predisponen a los pacientes a la AOS. El c\u00e1ncer orofar\u00edngeo (COF) puede aumentar el riesgo de AOS debido a los cambios en las v\u00edas respiratorias superiores inducidos por el tratamiento. Esta revisi\u00f3n que les comparto tuvo como objetivo evaluar la prevalencia de AOS en pacientes con COF despu\u00e9s del tratamiento.<\/p>\n\n\n\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n\n\n\n<p>Variations in upper airway anatomy and pharyngeal tone are factors that predispose patients to obstructive sleep apnea (OSA). Oropharyngeal cancer (OFC) can increase the risk of OSA due to treatment-induced changes in the upper airway. This review aimed to evaluate the prevalence of OSA in patients with OFC after treatment.<\/p>\n\n\n\n<p>Enlace\/Link: https:\/\/pubmed.ncbi.nlm.nih.gov\/41342092\/<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"269\" height=\"187\" src=\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg\" alt=\"images (89)\" class=\"wp-image-63177\" style=\"width:477px;height:auto\" srcset=\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg 269w, https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89-18x12.jpg 18w\" sizes=\"(max-width: 269px) 100vw, 269px\" \/><figcaption class=\"wp-element-caption\">images (89)<\/figcaption><\/figure>","protected":false},"excerpt":{"rendered":"<p>Las variaciones en la anatom\u00eda de las v\u00edas respiratorias superiores y el tono far\u00edngeo son factores que predisponen a los pacientes a la AOS. El c\u00e1ncer orofar\u00edngeo (COF) puede aumentar&hellip;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-63176","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento - Carlos O&#039;Connor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/carlosoconnor.es\/en\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento - Carlos O&#039;Connor\" \/>\n<meta property=\"og:description\" content=\"Las variaciones en la anatom\u00eda de las v\u00edas respiratorias superiores y el tono far\u00edngeo son factores que predisponen a los pacientes a la AOS. El c\u00e1ncer orofar\u00edngeo (COF) puede aumentar&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/carlosoconnor.es\/en\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/\" \/>\n<meta property=\"og:site_name\" content=\"Carlos O&#039;Connor\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-17T14:32:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-17T14:32:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"269\" \/>\n\t<meta property=\"og:image:height\" content=\"187\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"gestion\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"gestion\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/\"},\"author\":{\"name\":\"gestion\",\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949\"},\"headline\":\"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento\",\"datePublished\":\"2026-04-17T14:32:08+00:00\",\"dateModified\":\"2026-04-17T14:32:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/\"},\"wordCount\":149,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/carlosoconnor.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/\",\"url\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/\",\"name\":\"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento - Carlos O&#039;Connor\",\"isPartOf\":{\"@id\":\"https:\/\/carlosoconnor.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg\",\"datePublished\":\"2026-04-17T14:32:08+00:00\",\"dateModified\":\"2026-04-17T14:32:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#primaryimage\",\"url\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg\",\"contentUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/carlosoconnor.es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/carlosoconnor.es\/#website\",\"url\":\"https:\/\/carlosoconnor.es\/\",\"name\":\"Carlos O&#039;Connor\",\"description\":\"Dr. Carlos O&#039;Connor Reina - Otorrinolaring\u00f3logo\",\"publisher\":{\"@id\":\"https:\/\/carlosoconnor.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/carlosoconnor.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/carlosoconnor.es\/#organization\",\"name\":\"Carlos O&#039;Connor\",\"url\":\"https:\/\/carlosoconnor.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png\",\"contentUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png\",\"width\":241,\"height\":50,\"caption\":\"Carlos O&#039;Connor\"},\"image\":{\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949\",\"name\":\"gestion\",\"sameAs\":[\"https:\/\/www.ycomieronperdices.net\/temp\/oconnor2025\"],\"url\":\"https:\/\/carlosoconnor.es\/en\/author\/gestion\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento - Carlos O&#039;Connor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/carlosoconnor.es\/en\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/","og_locale":"en_GB","og_type":"article","og_title":"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento - Carlos O&#039;Connor","og_description":"Las variaciones en la anatom\u00eda de las v\u00edas respiratorias superiores y el tono far\u00edngeo son factores que predisponen a los pacientes a la AOS. El c\u00e1ncer orofar\u00edngeo (COF) puede aumentar&hellip;","og_url":"https:\/\/carlosoconnor.es\/en\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/","og_site_name":"Carlos O&#039;Connor","article_published_time":"2026-04-17T14:32:08+00:00","article_modified_time":"2026-04-17T14:32:11+00:00","og_image":[{"width":269,"height":187,"url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg","type":"image\/jpeg"}],"author":"gestion","twitter_card":"summary_large_image","twitter_misc":{"Written by":"gestion","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#article","isPartOf":{"@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/"},"author":{"name":"gestion","@id":"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949"},"headline":"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento","datePublished":"2026-04-17T14:32:08+00:00","dateModified":"2026-04-17T14:32:11+00:00","mainEntityOfPage":{"@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/"},"wordCount":149,"commentCount":0,"publisher":{"@id":"https:\/\/carlosoconnor.es\/#organization"},"image":{"@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#primaryimage"},"thumbnailUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg","articleSection":["Uncategorized"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/","url":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/","name":"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento - Carlos O&#039;Connor","isPartOf":{"@id":"https:\/\/carlosoconnor.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#primaryimage"},"image":{"@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#primaryimage"},"thumbnailUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg","datePublished":"2026-04-17T14:32:08+00:00","dateModified":"2026-04-17T14:32:11+00:00","breadcrumb":{"@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#primaryimage","url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg","contentUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/04\/images-89.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/carlosoconnor.es\/prevalencia-de-aos-en-pacientes-con-cancer-orofaringeo-despues-del-tratamiento\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/carlosoconnor.es\/"},{"@type":"ListItem","position":2,"name":"Prevalencia de AOS en pacientes con c\u00e1ncer orofar\u00edngeo despu\u00e9s del tratamiento"}]},{"@type":"WebSite","@id":"https:\/\/carlosoconnor.es\/#website","url":"https:\/\/carlosoconnor.es\/","name":"Carlos O&#039;Connor","description":"Dr. Carlos O&#039;Connor Reina - Otorrinolaring\u00f3logo","publisher":{"@id":"https:\/\/carlosoconnor.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/carlosoconnor.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/carlosoconnor.es\/#organization","name":"Carlos O&#039;Connor","url":"https:\/\/carlosoconnor.es\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/","url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png","contentUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png","width":241,"height":50,"caption":"Carlos O&#039;Connor"},"image":{"@id":"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949","name":"gestion","sameAs":["https:\/\/www.ycomieronperdices.net\/temp\/oconnor2025"],"url":"https:\/\/carlosoconnor.es\/en\/author\/gestion\/"}]}},"_links":{"self":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/63176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/comments?post=63176"}],"version-history":[{"count":1,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/63176\/revisions"}],"predecessor-version":[{"id":63178,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/63176\/revisions\/63178"}],"wp:attachment":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/media?parent=63176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/categories?post=63176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/tags?post=63176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}